For Patients

NavDx® is a clinically validated blood test for the early detection of HPV-associated cancers. Please fill out the form below if you are interested in learning more.
Publications

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer (Journal of Clinical Oncology, 2020)

Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer (Clinical Cancer Research 2019)

 

 

Follow us on:
Contact